pTij_sg_mmu_Med6_C_terminal
(Plasmid
#197869)
-
PurposeCRISPR/Cas9/sgRNA plasmid for cutting Med6 C terminal and building MED6-mEmerald/Halo knock-in mESCs
-
Depositing Lab
-
Publication
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 197869 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepTij_sgRNA_cloning_vector
-
Backbone manufacturerself-modified from pX330-U6-Chimeric_BB-CBh-hSpCas9
- Backbone size w/o insert (bp) 9757
- Total vector size (bp) 9759
-
Modifications to backboneinsert 20bp Med6 sgRNA sequence
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameMed6
-
Alt nameMed6
-
SpeciesM. musculus (mouse)
-
Insert Size (bp)20
-
Entrez GeneMed6 (a.k.a. 1500012F11Rik)
- Promoter U6
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site bbs1 (destroyed during cloning)
- 3′ cloning site bbs1 (destroyed during cloning)
- 5′ sequencing primer AGGGTCGGAACAGGAGAGC (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please visit https://www.biorxiv.org/content/10.1101/2022.10.26.513917v1 for bioRxiv preprint.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pTij_sg_mmu_Med6_C_terminal was a gift from James Zhe Liu (Addgene plasmid # 197869 ; http://n2t.net/addgene:197869 ; RRID:Addgene_197869) -
For your References section:
Spatial organization of the 3D genome encodes gene co-expression programs in single cells. Dong P, Zhang S, Xie L, Wang L, Lemire AL, Lander AD, Chang HY, Liu ZJ. bioRxiv 2022.10.26.513917 10.1101/2022.10.26.513917